Pfizer News Today - Search News

Pfizer tops earnings estimates

Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.

Reuters · 3d

Pfizer shows profit growth from cost cuts and steadier COVID sales

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings related to its COVID-19 vaccine.

Investor's Business Daily on MSN · 3d

Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations

Pfizer stock rose moderately early Tuesday as better-than-expected Covid product sales helped drive a fourth-quarter beat.

Pfizer, Super Bowl

FiercePharma · 21h

Don't call it a comeback: Pfizer returns to Super Bowl with ad pledging to 'knock out' cancer

Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for

Ad Age · 20h

Watch Pfizer’s Super Bowl ad showing a patient’s cancer-fighting story

Pfizer is again shining a spotlight on its oncology treatments with its second consecutive Super Bowl ad, a 60-second commercial that will air in the first quarter of the game on Sunday. The ad begins with a young boy in a hospital bed watching announcer Michael Buffer on TV.

ADWEEK on MSN · 20h

Pfizer Teams Up With LL Cool J In Super Bowl Ad, Literally Fighting Cancer

Picking up from where last year's Big Game ad debut left off, Pfizer wants to bring a note of resilience and motivation to those fighting cancer in its Super Bowl 59 spot. In the ad, a young boy gets out of his hospital bed,

12h

US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

BioPharma Dive10h

Pfizer taps former Novartis exec to lead cancer drug push

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

2don MSN

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

3don MSN

Pfizer's CEO says he's had dinner with Trump's health secretary pick, RFK Jr.

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Pfizer’s Covid Boost Overshadowed by Kennedy Threat to Vaccines

Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...

FierceBiotech3d

Pfizer axes B7-H4 ADC, triggering $1B impairment charge as blockbuster vision evaporates

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

PFE Earnings: Pfizer Stock Jumps on Q4 Beats

Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company ...

Pfizer Beats Q4 Revenue, EPS Estimates

Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.

Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

Pfizer imposes its drugs in Russia, and the money goes APU — TC Readovka

Despite loud statements about leaving, the American company Pfizer continues to promote its drugs in Russia, using opaque schemes, and transfers part of the income to the Armed Forces of Ukraine.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results